BioSpace News Archive

Immune-Onc Therapeutics (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, today announced the appointments of Dr. Adrian Jubb as Chief Medical Officer and of Dr. An Song as Senior Vice President of Development Sciences.

The first-of-its-kind-program will provide hands-on community activations during Chicago Ideas Week

Bio-Techne today announced the online publication of its second prospective US clinical validation study of the Exosome Diagnostics-branded ExoDx® Prostate(IntelliScore) (EPI)

Feinstein Institute for Medical Research Assistant Professor Catherine Benedict, PhD, has been awarded a five-year, $693,000 grant from the National Institutes of Health (NIH) to develop and test a digital health platform to help young female cancer survivors evaluate their options for having children, make decisions and plan for the future.

The global hereditary angioedema therapeutics market 2018-2022 is expected to post a CAGR of close to 9% during the forecast period, according to the latest markey research report by Technavio.

Technavio has announced their latest drug pipeline analysis report on herpes zoster

Capital Advisors Group, Inc., today announced that Stefan Spazek has been selected to lead the firm’s Debt Finance Consulting Group.

Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today announced its initiation of the second and third of three planned Phase 3 clinical trials for sulopenem, Iterum’s lead compound and novel antibiotic for the treatment of gram-negative, multi-drug resistant infections.

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for cardiovascular diseases, today announced that it has submitted a Special Protocol Assessment (SPA) request to the U.S. Food and Drug Administration (FDA).

CloudLIMS is hosting a live webinar on September 25, 2018, on Biospecimen Quality for Precision Medicine.